Skip to main content

Table 2 Clinical assessments

From: A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol

Clinician-Administered Assessments

 Mini International Neuropsychiatric Interview (MINI)

 Montgomery-Åsberg Depression Rating Scale (MADRS)

 Clinical Global Impression (CGI)

 Young Mania Rating Scale (YMRS)

 Columbia-Suicide Severity Rating Scale (C-SSRS)

 Toronto Side Effects Scale (TSES)

 Montreal Cognitive Assessment (MOCA)

 CNS Vital Signs (CNS-VS), Computerized neurocognitive battery

Self-Report Assessments

 Patient Health Questionnaire (PHQ-9)

 Generalized Anxiety Disorder 7-item scale (GAD-7)

 Quality of Life, Enjoyment and Satisfaction Questionnaire-short form (Q-LESQ-SF)

 Dimensional Anhedonia Rating Scale (DARS)

 Medical Outcome Study - short Form 36 (SF-36)

 Drug Abuse Screening Test (DAST-10)

 Beck Scale for Suicide Ideation (BSS)